Infectious Diseases News and Research

RSS

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

While several COVID-19 vaccines have been approved to date, the constant evolution of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) receptor-binding domain (RBD) has challenged the efficacy of these vaccines.

11 Jun 2021

ACTG launches phase 1 HIV cure study evaluating two promising therapies

The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.

10 Jun 2021

Are pre-existing Vitamin D deficiencies linked to COVID-19 severity and mortality?

Even as the COVID-19 pandemic continues to spread and new variants of SARS-CoV-2 emerge, much remains to be known about why severity varies so unpredictably between individuals. A new study, released as a preprint on the medRxiv* server, elucidates the relationship between Vitamin D and COVID-19 severity.

10 Jun 2021

Trained dogs can accurately identify COVID-19 by scent

An interesting new medRxiv* preprint reveals that with careful training, the exquisite scent sensitivity of dogs may be exploited to rule out the presence of coronavirus disease 2019 (COVID-19) in human beings in real-time.

9 Jun 2021

Clinical trial investigates effectiveness of delivering HIV, substance use care through mobile clinics

A clinical trial is underway in five U.S. cities to determine whether delivering integrated health services through mobile clinics can improve HIV and substance use outcomes among people with opioid use disorder who inject drugs.

9 Jun 2021

Fish oil may help fight against superbugs

For the first time, Australian scientists have confirmed a link between the role of regular fish oil to break down the ability of 'superbugs' to become resistant to antibiotics.

9 Jun 2021

Study explores the immune response to COVID-19-specific vaccines in Brazilian healthcare workers

An Australian-led study will investigate whether it's possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.

9 Jun 2021

Surgical masks effectively reduce outgoing airborne particles, despite leakage at edges

A new study from the University of California, Davis and the Icahn School of Medicine at Mount Sinai confirms that surgical masks effectively reduce outgoing airborne particles from talking or coughing, even after allowing for leakage around the edges of the mask. The results are published June 8 in Scientific Reports.

9 Jun 2021

SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

The report, published in the journal Clinical Infectious Diseases, revealed that the variant detected has been spreading at an alarming rate since November. By February 2021, it accounted for 12.3 percent of all cases in the area.

8 Jun 2021

TSMC grant could boost TGen's efforts to track SARS-CoV-2 variants

The Translational Genomics Research Institute, an affiliate of City of Hope, today announced a substantial grant from Taiwan Semiconductor Manufacturing Co. Ltd., one of the world's largest manufacturers of computer chips, to help TGen sustain Arizona's fight against COVID-19.

8 Jun 2021

SARS-CoV-2 immunity persists for up to 11 months after natural infection

The study, published in the Journal of Infectious Diseases, determined how circulating antibody levels change after being infected with SARS-CoV-2.

8 Jun 2021

The potential of mRNA vaccines for a wide range of diseases

A new review article published in the journal Briefings in Functional Genomics focuses on the general characteristic features and mechanisms of mRNA vaccines. Further, this review has summarized the current progress of mRNA vaccines that have been developed for wide-ranging diseases, including COVID-19 disease.

8 Jun 2021

Bacteria causing urinary tract infections can originate in meat-production chain

In young women, Staphylococcus saprophyticus is a main cause of urinary tract infections (UTI), reaching 20% prevalence. Understanding the epidemiology of this microorganism can help identify its origin, distribution, causes, and risk factors.

8 Jun 2021

Experimental monoclonal antibody could be a new weapon against HIV epidemic

An experimental, lab-made antibody can completely prevent nonhuman primates from being infected with the monkey form of HIV, new research published in Nature Communications shows.

7 Jun 2021

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has completed enrollment and randomized the last patient in the global Phase 2/3 study with opaganib (Yeliva, ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840).

7 Jun 2021

Study shows why COVID-19 has widely varying outcomes in different people

The answer is something infectious disease experts are working to uncover. As COVID-19 revealed, the same pathogen can have widely varying outcomes in different people.

7 Jun 2021

Study suggests prolonged, strict restrictions did not necessarily reduce COVID-19 mortality

A multi-national team of researchers compared COVID-19-related data from different countries in order to better understand the various factors leading to the different results across the world. The multi-disciplinary team included data scientists, software developers, and an infectious diseases physician.

7 Jun 2021

New study investigates how green tea could lead to a drug for tackling Covid-19

As India continues to be ravaged by the pandemic, a Swansea University academic is investigating how green tea could give rise to a drug capable of tackling Covid-19.

5 Jun 2021

Georgia State professor receives federal grant to study seasonal and universal vaccination in elderly populations

Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.7 million federal grant to study seasonal and universal vaccination in elderly populations with pre-existing immunity to influenza viruses.

5 Jun 2021

Mason researchers examine the potential anti-coronavirus activities of an over-the-counter drink

Could an over-the-counter health "shot" help fight COVID-19? George Mason University researchers think it just might.

5 Jun 2021

Infectious Diseases News and Research

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

ACTG launches phase 1 HIV cure study evaluating two promising therapies

Are pre-existing Vitamin D deficiencies linked to COVID-19 severity and mortality?

Trained dogs can accurately identify COVID-19 by scent

Clinical trial investigates effectiveness of delivering HIV, substance use care through mobile clinics

Fish oil may help fight against superbugs

Study explores the immune response to COVID-19-specific vaccines in Brazilian healthcare workers

Surgical masks effectively reduce outgoing airborne particles, despite leakage at edges

SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

TSMC grant could boost TGen's efforts to track SARS-CoV-2 variants

SARS-CoV-2 immunity persists for up to 11 months after natural infection

The potential of mRNA vaccines for a wide range of diseases

Bacteria causing urinary tract infections can originate in meat-production chain

Experimental monoclonal antibody could be a new weapon against HIV epidemic

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Study shows why COVID-19 has widely varying outcomes in different people

Study suggests prolonged, strict restrictions did not necessarily reduce COVID-19 mortality

New study investigates how green tea could lead to a drug for tackling Covid-19

Georgia State professor receives federal grant to study seasonal and universal vaccination in elderly populations

Mason researchers examine the potential anti-coronavirus activities of an over-the-counter drink

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News